Skip to main content

Table 3 The results of meta-regression analyses

From: Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis

Model Covariates Meta-regression β coefficient (SE) 95% CI of β coefficient p value
Pooled RR for included studies (Figure 2) Age at HL diagnosis Latency since HL treatment −0.105 (0.015) −0.010 (0.031) −0.137 to −0.072 −0.075 to 0.055 <0.0001 0.747
RR versus follow-up intervals (Figure 6) Age at HL diagnosis −0.036 (0.010) −0.057 to −0.015 0.001
RR versus therapy modality (Figure 7): RT vs. RT + C vs. C Age at HL diagnosis Latency since HL treatment −0.099 (0.027) −0.095 (0.073) −0.157 to −0.041 −0.251 to 0.061 0.003 0.212
  1. C chemotherapy, CI confidence interval, HL Hodgkin’s lymphoma, RR relative risk, RT radiotherapy, SE standard error.
\